2023 Speaker Faculty Adrian Hayday Group Leader The Francis Crick Institute Aleksandra Filipovic Head of Oncology PureTech Health Andy Bader Chief Scientific Officer Triumvira Angela Justice Chief People Officer TCR2 Therapeutics Beau Webber Chief Scientific Officer & Founder Luminary Therapeutics Blake Aftab Chief Scientific Officer Adicet Bio Bruno Silva-Santos Group Leader Institute of Molecular Medicine - IMM Caroline Hull Associate Director Leucid Bio Christopher Holland Manager, Experimental Immunology Immunocore Daniel Abate-Daga Associate Member H. Lee Moffitt Cancer Center & Research Institute Daniel Olive Team Leader, CCRM Centre de Recherche en Cancérologie de Marseille Dorothee Bourges Lab Head, Pharmacology, Immuno-oncology Sanofi Emiliano Roselli Senior Scientist Regeneron Pharmaceuticals Inc Hans Van der Vliet Chief Scientific Officer LAVA Therapeutics Huan Yang Associate Principal Scientist Merck Hunter Jonus Postdoctoral Fellow Emory University Inbar Alfaguter Senior Scientist Immatics GmbH Jay Mills Director of Process Development Century Therapeutics Jeff Liter President & Chief Executive Officer Luminary Therapeutics Jeff Liter President & Chief Executive Officer Luminary Therapeutics Joshua Kellner Senior Director Manufacturing Science & Technology Kiromic Biopharma Kate Rochlin Chief Operating Officer IN8bio Kelly Goldsmith Professor Emory University Kok Fei Chan Research Fellow Olivia Newton-John Cancer Research Institute Lawrence Lamb Executive Vice President & Chief Scientific Officer IN8Bio Leticia Tordesillas Research Scientist Moffitt Cancer Center Michael Lotze Professor of Surgery, Immunology and Bioengineering University of Pittsburgh Michael Traxlmayr Senior Scientist BOKU Paul Frohna Chief Medical Officer ImCheck Therapeutics Sophie Agaugue Vice President - Preclinical Research ImCheck Therapeutics Wee Kiat Tan Chief Operating Officer CytoMed Therapeutics Wei Liang Associate Director, Research & Development Ansun Biopharma Wei Weng CEO InGenious Targeting Laboratory William Ho Chief Executive Officer IN8bio Yu Qian Associate Director, CMC, Cell Therapies Takeda